Cumberland Pharmaceuticals Inc. Common Stock, Value, Outstanding
Cumberland Pharmaceuticals Inc. (CPIX) had Common Stock, Value, Outstanding of $51.81 million as of 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Balance Sheet › Equity › Stockholders' Equity, Number of Shares, Par Value and Other Disclosure › Common Stock, Number of Shares, Par Value and Other Disclosure
us-gaap:CommonStockValueOutstanding · last filed 2026-08-07
- 2026-06-30: Common Stock, Value, Outstanding $51.81M.
- 2026-03-31: Common Stock, Value, Outstanding $51.73M.
- 2025-12-31: Common Stock, Value, Outstanding $51.68M.
- 2025-09-30: Common Stock, Value, Outstanding $51.51M.
| Period end | Common Stock, Value, Outstanding | Common Stock, Value, Outstanding as first filed |
|---|---|---|
| 2026-06-30 | $51.81M 10-Q · filed 2026-08-07 | |
| 2026-03-31 | $51.73M 10-Q · filed 2026-05-08 | |
| 2025-12-31 | $51.68M 10-Q · filed 2026-08-07 | |
| 2025-09-30 | $51.51M 10-Q · filed 2025-11-07 | |
| 2025-06-30 | $51.44M 10-Q · filed 2025-08-08 | |
| 2025-03-31 | $51.37M 10-Q · filed 2025-05-09 | |
| 2024-12-31 | $46.82M 10-K · filed 2026-03-09 | |
| 2024-09-30 | $46.84M 10-Q · filed 2024-11-08 | |
| 2024-06-30 | $46.87M 10-Q · filed 2024-08-09 | |
| 2024-03-31 | $46.92M 10-Q · filed 2024-05-10 | |
| 2023-12-31 | $47.09M 10-K · filed 2025-03-07 | |
| 2022-12-31 | $47.47M 10-K · filed 2024-03-13 | |
| 2021-12-31 | $48.45M 10-K · filed 2023-03-13 | |
| 2020-12-31 | $49.12M 10-K · filed 2022-03-11 | |
| 2019-12-31 | $49.91M 10-K · filed 2021-03-12 | |
| 2018-12-31 | $51.10M 8-K · filed 2020-12-10 | |
| 2017-12-31 | $52.41M 10-K · filed 2019-03-12 | |
| 2016-12-31 | $54.64M 10-K · filed 2018-03-09 | |
| 2015-12-31 | $57.34M 10-K · filed 2017-03-13 | |
| 2014-12-31 | $61.94M 10-K · filed 2016-03-14 | |
| 2013-12-31 | $63.07M 10-K · filed 2015-03-09 | |
| 2013-09-30 | $80.93M 10-Q · filed 2013-11-06 | |
| 2013-06-30 | $82.87M 10-Q · filed 2013-08-09 | |
| 2013-03-31 | $85.03M 10-Q · filed 2013-05-08 | |
| 2012-12-31 | $67.20M 10-K · filed 2014-03-11 | |
| 2012-09-30 | $83.33M 10-Q · filed 2012-11-02 | |
| 2012-06-30 | $83.21M 10-Q · filed 2012-08-09 | |
| 2012-03-31 | $81.85M 10-Q · filed 2012-05-04 | |
| 2011-12-31 | $70.27M 10-K · filed 2013-03-12 | $82.84M 10-K · filed 2012-03-07 |
| 2011-09-30 | $83.46M 10-Q · filed 2011-11-07 | |
| 2011-06-30 | $81.43M 10-Q · filed 2011-08-08 | |
| 2010-12-31 | $77.72M 10-K · filed 2012-03-07 | |
| 2009-12-31 | $72.22M 10-K · filed 2012-03-07 | |
| 2008-12-31 | $17.55M 10-K · filed 2012-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |